Literature DB >> 31359126

Strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy.

Yan Xu1,2, Lijing Zhu3, Li Zhu1, Huanhuan Wang1, Tong Ru2, Baorui Liu3, Jian He1, Sibo Tian4, Zhengyang Zhou5, Xiaofeng Yang6.   

Abstract

OBJECTIVE: To explore the value of strain elastography as an early predictor of long-term prognosis in patients with locally advanced cervical cancers treated with concurrent chemoradiotherapy (CCRT).
METHODS: Strain elastography examinations were performed on 45 patients with locally advanced cervical cancers at 3 time points: prior to CCRT, and at 1 and 2 weeks after the start of CCRT. The maximum tumor diameter (Dmax), strain ratio (SR), and their percentage changes (ΔDmax and ΔSR) were calculated to predict long-term prognosis. Based on the results of physical examinations, Papanicolaou test, and pelvic magnetic resonance imaging, we classified patients into two groups: responders (complete remission) and non-responders (sustained disease, recurrence, or death).
RESULTS: After a median follow-up of 30 months (range, 12-36 months), 36 of 45 (80%) patients were disease free. The Dmax as well as ΔDmax at 2 weeks during CCRT was able to predict the responder outcomes, with an area-under-the-curve (AUC) of 0.733 and 0.731, respectively. Furthermore, significant differences in SR and ΔSR at 1 and 2 weeks during therapy were shown between the responder and non-responder groups (all p < 0.05), and ΔSR at 2 weeks during CCRT presented with the highest AUC (0.91), yielding 88.9% sensitivity and 88.9% specificity with a selected cutoff value.
CONCLUSIONS: Strain elastography may be useful as an early predictor of long-term outcomes after CCRT for patients with cervical cancer. KEY POINTS: • The D maxas well as ΔD maxat 2 weeks during CCRT can predict the responder outcomes. • The elastography parameters (SR and ΔSR) exhibited predictive values of favorable response after therapy initiation. • ΔSR at 2 weeks during CCRT held the best predictive value for the responder outcomes.

Entities:  

Keywords:  Cervical cancer; Concurrent chemoradiotherapy; Elastography; Treatment outcome

Mesh:

Year:  2019        PMID: 31359126     DOI: 10.1007/s00330-019-06345-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  36 in total

1.  Semiquantitative strain elastography of liver masses.

Authors:  Mehmet Ruhi Onur; Ahmet Kursad Poyraz; Esra Ercin Ucak; Zulkif Bozgeyik; Ibrahim Hanifi Özercan; Erkin Ogur
Journal:  J Ultrasound Med       Date:  2012-07       Impact factor: 2.153

2.  Clinical significance of tumor volume and lymph node involvement assessed by MRI in stage IIB cervical cancer patients treated with concurrent chemoradiation therapy.

Authors:  Dae Woo Lee; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Eun Ji Nam; Jae Wook Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

3.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

4.  Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective randomized phase III trial.

Authors:  A Dueňas-González; M Orlando; Y Zhou; M Quinlivan; H Barraclough
Journal:  Gynecol Oncol       Date:  2012-06-09       Impact factor: 5.482

5.  Comparison of real-time sonoelastography with T2-weighted endorectal magnetic resonance imaging for prostate cancer detection.

Authors:  Friedrich Aigner; Leo Pallwein; Michael Schocke; Andrei Lebovici; Lebovici Andrei; Daniel Junker; Georg Schäfer; Gregor Mikuz; Florian Pedross; Wolfgang Horninger; Werner Jaschke; Ethan J Halpern; Ferdinand Frauscher
Journal:  J Ultrasound Med       Date:  2011-05       Impact factor: 2.153

6.  Younger age as a bad prognostic factor in patients with carcinoma of the cervix.

Authors:  J F Delaloye; S Pampallona; P A Coucke; P De Grandi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-02       Impact factor: 2.435

Review 7.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

8.  Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study.

Authors:  Kimio Ushijima; Keizo Fujiyoshi; Kouichiro Kawano; Naotake Tsuda; Shin Nishio; Hidehiro Eto; Toshiharu Kamura
Journal:  J Gynecol Oncol       Date:  2013-04-05       Impact factor: 4.401

9.  Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.

Authors:  Yan Xu; Lijing Zhu; Baorui Liu; Tong Ru; Huanhuan Wang; Jian He; Song Liu; Xiaofeng Yang; Zhengyang Zhou; Tian Liu
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430

10.  Accuracy of visual scoring and semi-quantification of ultrasound strain elastography--a phantom study.

Authors:  Jonathan Frederik Carlsen; Caroline Ewertsen; Adrian Săftoiu; Lars Lönn; Michael Bachmann Nielsen
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more
  1 in total

1.  Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway.

Authors:  Xiaoxia Zheng; Yanan Zhu; Xiaoping Wang; Yanmei Hou; Yingji Fang
Journal:  Ann Transl Med       Date:  2021-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.